Results 221 to 230 of about 262,665 (314)

Estrogen receptor α regulates SVCT2 protein level in human breast cancer cells. [PDF]

Sci Rep
Jang SY, Hong E, Jo Y, Kim J, Kim JH, Na Y, Yeom CH, Yang YJ, Jacchetti E, Raimondi MT, Park S.   +10 more
europepmc   +1 more source

Evaluation of the Pathologic and Prognostic Correlates of Estrogen Receptors in Primary Breast Cancer

, 1982
James R. Skinner, Harold J. Wanebo, William L. Betsill, Morton C. Wilhelm, Charles R. Drake, Robert M. MacLeod   +5 more
openalex   +2 more sources

Sex Differences in Auditory Brainstem Responses of Two Rat Models of Autism: Environmental and Genetic Contributions to Autism‐Like Auditory Function

Autism Research, EarlyView.
ABSTRACT Autism is an early‐onset neurodevelopmental disorder characterized by restricted, repetitive behaviors and atypical patterns of social communication and interaction. A considerable proportion of autistic individuals experience divergent auditory perception, which can interfere with their ability to navigate everyday sound environments ...
Sara Cacciato‐Salcedo, Ana B. Lao‐Rodríguez, Manuel S. Malmierca   +2 more
wiley   +1 more source

Long-Chain Fatty Acids Alter Estrogen Receptor Expression in Breast Cancer Cells. [PDF]

Int J Mol Sci
Ogata R, Luo Y, Fujiwara-Tani R, Sasaki R, Ikemoto A, Maehana K, Sasaki A, Sasaki T, Fujii K, Ohmori H, Kuniyasu H.   +10 more
europepmc   +1 more source

Real‐world treatment patterns among patients diagnosed with hormone receptor‐positive metastatic breast cancer in the USA

British Journal of Clinical Pharmacology, EarlyView.
Aims Clinical guidelines for breast cancer management have evolved in the past decade. However, limited evidence exists regarding uptake of novel drug classes in management of hormone receptor‐positive (HR+) metastatic breast cancer (MBC) in the USA and whether disparities exist by race and ethnicity.
Kexin Zhu, Coral O. Omene, Antoinette Stroup, Elisa V. Bandera, Farzin Khosrow‐Khavar   +4 more
wiley   +1 more source

TENT5C functions as a corepressor in the ligand-bound glucocorticoid receptor and estrogen receptor α complexes. [PDF]

FEBS J
Li Y, Perera L, He RS, Baptissart M, Petrovich RM, Morgan M.   +5 more
europepmc   +1 more source

Effect of vepdegestrant, a PROTAC oestrogen receptor degrader, on dabigatran and rosuvastatin pharmacokinetics in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aims To evaluate the effects of vepdegestrant, a PROteolysis TArgeting Chimera (PROTAC) oestrogen receptor degrader, on the pharmacokinetics of dabigatran (a P‐glycoprotein [P‐gp] substrate) and rosuvastatin (a breast cancer resistance protein [BCRP] substrate).
Derek Z. Yang, Li Zhou, Jennifer A. Winton, Kyle T. Matschke, Constantino Kantaridis, Kristine Doyle, Kimberly C. Lee, Naihan Chen, Yuanyuan Zhang, Weiwei Tan   +9 more
wiley   +1 more source

PARP14-mediated glycolysis enhances Tamoxifen resistance in estrogen receptor + breast cancer cells. [PDF]

Discov Oncol
Mo W, Zhang F, Wang C, Ding X, Ren L.
europepmc   +1 more source

Innovative transdermal drug delivery systems: Benefits, challenges, and emerging application

BMEMat, EarlyView.
The graphical abstract illustrates the diverse nanostructures employed in transdermal drug delivery systems, highlighting their unique mechanisms to penetrate the intricate layers of skin. It provides a detailed representation of the skin's complex anatomy, emphasizing the challenges posed by its barrier properties.
Syed Waqas Ali Shah, Xingxing Li, Hao Yuan, Huiling Shen, Shaohao Quan, Guifang Pan, Muhammad Ishfaq, Abid Ullah Shah, Hanhan Xie, Jundong Shao   +9 more
wiley   +1 more source

Androgen receptor antagonist flutamide modulates estrogen receptor alpha expression in distinct regions of the hypospadiac rat penis. [PDF]

Front Endocrinol (Lausanne)
Elmelund E, Draskau MK, Berg M, Strand IW, Black JR, Axelstad M, Pask AJ, Svingen T.   +7 more
europepmc   +1 more source